KNSA
KINIKSA PHARMA (KNSA)
NASDAQ
$76.51+$0.23 (+0.31%)
Price as of Sep 11, 2026 7:30 PM EDT
  • $3.2B
    Market Cap
  • 105.58%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 72
Valuation
KNSA
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 87
Valuation
KNSA
vs History
vs S&P 500
3-Month Momentum
60.47%
12-Month Momentum
111.16%
3-Month Risk Adjusted Momentum
197.29%
12-Month Risk Adjusted Momentum
226.60%

True Yield

N/A
Valuation
KNSA
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 71
Valuation
KNSA
vs History
vs S&P 500
Ohlson's O-Score
10